ARS Pharmaceuticals SPRY
NASDAQ SPRY
$3.59 +0.43 (+13.81%)
As of: Nov 10, 2026 · 1:53 PM EST

ARS Pharmaceuticals (SPRY) EV to EBIT (2022)

Updated

ARS Pharmaceuticals' (SPRY) EV to EBIT was -2.91 for Q3 2022.

Analysis

ARS Pharmaceuticals (SPRY) EV to EBIT (2022) Analysis & Trends

Over the twelve months ended Sep 30, 2022, ARS Pharmaceuticals' EV to EBIT came in at -24.45.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 ARS Pharmaceuticals 335.94 Mn 197.54 Mn 27.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -2.91
Jun 30, 2022 -10.37
API Access

ARS Pharmaceuticals EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=SPRY&period=max&api_key=YOUR_API_KEY